Fresenius SE & Co. (OTCMKTS:FSNUY) Sets New 12-Month Low – Should You Sell?

Posted by George Bondi on May 23rd, 2026

Shares of Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) hit a new 52-week low on Saturday . The stock traded as low as $11.13 and last traded at $11.37, with a volume of 162311 shares trading hands. The stock had previously closed at $11.84.

Analysts Set New Price Targets

Several research analysts have recently weighed in on FSNUY shares. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy”.

Get Our Latest Stock Analysis on Fresenius SE & Co.

Fresenius SE & Co. Stock Performance

The company has a market capitalization of $25.62 billion, a price-to-earnings ratio of 15.16 and a beta of 0.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32. The company’s fifty day simple moving average is $12.48 and its two-hundred day simple moving average is $13.76.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. Equities research analysts predict that Fresenius SE & Co. will post 1.05 earnings per share for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.